Shares of Amryt Pharma plc (LON:AMYT – Get Free Report) were down 11.7% during mid-day trading on Thursday . The stock traded as low as GBX 143 ($1.80) and last traded at GBX 143 ($1.80). Approximately 90,726 shares changed hands during mid-day trading, a decline of 81% from the average daily volume of 469,552 shares. The stock had previously closed at GBX 162 ($2.04).
Amryt Pharma Trading Down 11.7 %
The company has a fifty day simple moving average of GBX 143 and a two-hundred day simple moving average of GBX 143. The company has a current ratio of 1.80, a quick ratio of 1.14 and a debt-to-equity ratio of 66.05. The company has a market cap of £457.11 million and a PE ratio of -4.33.
Amryt Pharma Company Profile
Amryt Pharma plc, a commercial-stage biopharmaceutical company, develops and commercializes novel therapeutics to treat patients suffering from serious and life-threatening rare diseases. The company offers Lomitapide for the treatment of homozygous familial hypercholesterolemia; and Metreleptin for the treatment of generalized and partial lipodystrophy.
Recommended Stories
- Five stocks we like better than Amryt Pharma
- How to Know if a Stock Pays Dividends and When They Are Paid Out
- Why Palo Alto Networks’ Multi-Year Uptrend Is Far From Over
- The Significance of Brokerage Rankings in Stock Selection
- 3 Rock-Solid Buying Opportunities in the Market Right Now
- Why Invest in High-Yield Dividend Stocks?
- TJX Companies Stock Poised to Hit a New High This Year
Receive News & Ratings for Amryt Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amryt Pharma and related companies with MarketBeat.com's FREE daily email newsletter.
